Dr Pauline Ashfield-Watt

2022

• Phillips, R. et al. 2022. Perceived threat of COVID-19, attitudes towards vaccination, and vaccine hesitancy: A prospective longitudinal study in the UK. British Journal of Health Psychology 27(4), pp. 1354-1381. (10.1111/bjhp.12606)

2021

• Phillips, R. et al. 2021. Cohort profile: The UK COVID-19 Public Experiences (COPE) prospective longitudinal mixed-methods study of health and well-being during the SARSCoV2 coronavirus pandemic. PLoS ONE 16(10), article number: e0258484. (10.1371/journal.pone.0258484)
• Bracchi, R. C. et al. 2021. Public awareness in Wales of the UK Yellow Card Scheme for reporting suspected adverse drug reactions. British Journal of Clinical Pharmacology 87(8), pp. 3344-3348. (10.1111/bcp.14726)

2020

• Townson, J., Davies, J., Hurt, L., Ashfield-Watt, P. and Paranjothy, S. 2020. Developing and evaluating a model of public involvement and engagement embedded in a national longitudinal study: HealthWise Wales. International Journal of Population Data Science 5(3), article number: 3. (10.23889/ijpds.v5i3.1356)

2019

• Hurt, L. et al. 2019. Cohort Profile: HealthWise Wales. A research register and population health data platform with linkage to National Health Service datasets in Wales. BMJ Open 9(12), article number: e031705. (10.1136/bmjopen-2019-031705)
• Tseliou, F., Atkinson, M., Paranjothy, S. and Ashfield-Watt, P. 2019. Do carers care for themselves? A population-based study. International Journal of Population Data Science 4(3), article number: 54. (10.23889/ijpds.v4i3.1215)
• Ashfield-Watt, P. et al. 2019. Estimation of the prevalence of cholesteryl ester storage disorder in a cohort of patients with clinical features of familial hypercholesterolaemia. Annals of Clinical Biochemistry 56(1), pp. 112-117. (10.1177/0004563218793165)

2016

• Haralambos, K., Ashfield-Watt, P. A. L. and McDowell, I. F. 2016. Diagnostic scoring for familial hypercholesterolaemia in practice. Current Opinion in Lipidology 27(4), pp. 367-374. (10.1097/MOL.0000000000000325)
• Abreu, J. et al. 2016. Relationship between measurements of non-HDL-cholesterol and LDL-cholesterol in Familial Hypercholesterolaemia. Atherosclerosis 245, pp. e247. (10.1016/j.atherosclerosis.2015.10.037)
• Ashfield-Watt, P. A. L. et al. 2016. Web based tools to assess eligibility for genetic testing for Familial Hypercholesterolaemia (FH). Atherosclerosis 245, pp. e245. (10.1016/j.atherosclerosis.2015.10.033)

2015

• Haralambos, K. et al. 2015. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales. Atherosclerosis 240(1), pp. 190-196. (10.1016/j.atherosclerosis.2015.03.003)

2003

• Moat, S. J. et al. 2003. Reduction in plasma total homocysteine through increasing folate intake in healthy individuals is not associated with changes in measures of antioxidant activity or oxidant damage. European Journal of Clinical Nutrition 57(3), pp. 483-489. (10.1038/sj.ejcn.1601554)
• Burr, M. L. et al. 2003. Lack of benefit of dietary advice to men with angina: results of a controlled trial. European Journal of Clinical Nutrition 57(2), pp. 193-200. (10.1038/sj.ejcn.1601539)
• Ashfield-Watt, P. A. L., Whiting, J. M., Clark, Z. E., Moat, S. J., Newcombe, R. G., Burr, M. L. and McDowell, I. F. 2003. A comparison of the effect of advice to eat either '5-a-day' fruit and vegetables or folic acid-fortified foods on plasma folate and homocysteine. European Journal of Clinical Nutrition 57(2), pp. 316-323. (10.1038/sj.ejcn.1601545)
• Moat, S. J., Ashfield-Watt, P. A. L., Powers, H. J., Newcombe, R. G. and McDowell, I. F. 2003. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype. Clinical chemistry 49(2), pp. 295-302. (10.1373/49.2.295)

2002

• Ashfield-Watt, P. A. L. et al. 2002. Methylenetetrahydrofolate reductase 677C-->T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial. American Journal of Clinical Nutrition 76(1), pp. 180-186.
• Ashfield-Watt, P. A. L., Clark, Z. E., Breay, P., Zotos, P. C., Cale, S. B., Burr, M. L. and McDowell, I. F. 2002. Nutritional advice to increase soluble fibre intake does not change plasma folate or homocysteine in men with angina: a randomised controlled trial. Public Health Nutrition 5(1), pp. 47-53. (10.1079/PHN2001250)
• Ashfield-Watt, P. A. L. et al. 2002. Methylenetetrahydrofolate reductase 677CT genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial. American Journal of Clinical Nutrition 76(1), pp. 180-186.

2000

• McDowell, I. F., Ashfield-Watt, P. A. L., Clark, Z. E., Cale, S. B., Breay, P., Payne, N. and Burr, M. L. 2000. Plasma homocysteine, folate and methylenetetrahydrofolate reductase genotype in men with angina: a controlled trial of dietary intervention to increase soluble dietary fibre [Abstract]. Proceedings of the Nutrition Society 59(OCB), pp. 145A.